High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: pilot study.
about
Leflunomide reduces proliferation and induces apoptosis in neuroblastoma cells in vitro and in vivo28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures.Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastomaRetrospective analysis of peripheral blood stem cell transplantation for the treatment of high-risk neuroblastomaLong-term results of high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma patients: a report of the Spanish working party for BMT in children (Getmon).
P2860
High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: pilot study.
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
High-dose systemic interleukin ...... transplantation: pilot study.
@ast
High-dose systemic interleukin ...... transplantation: pilot study.
@en
type
label
High-dose systemic interleukin ...... transplantation: pilot study.
@ast
High-dose systemic interleukin ...... transplantation: pilot study.
@en
prefLabel
High-dose systemic interleukin ...... transplantation: pilot study.
@ast
High-dose systemic interleukin ...... transplantation: pilot study.
@en
P2093
P2860
P1476
High-dose systemic interleukin ...... transplantation: pilot study.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1096-911X(199612)27:6<534::AID-MPO5>3.0.CO;2-M
P577
1996-12-01T00:00:00Z